Clinical Characteristics and Outcomes of Diabetic Ketoacidosis in Patients With Type 2 Diabetes using SGLT2 Inhibitors

BACKGROUND: Sodium glucose cotransporter 2 inhibitors (SGLT2i) use is associated with an increased risk of diabetic ketoacidosis (DKA). OBJECTIVE: This study evaluated and compared the DKA characteristics and outcomes of users and non-users of SGLT2i. METHODS: We retrospectively studied patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Almazrouei, Raya, Afandi, Bachar, AlKindi, Fatima, Govender, Romona, Al-Shamsi, Saif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943955/
https://www.ncbi.nlm.nih.gov/pubmed/36844982
http://dx.doi.org/10.1177/11795514231153717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943955/
https://www.ncbi.nlm.nih.gov/pubmed/36844982
http://dx.doi.org/10.1177/11795514231153717

Ejemplares similares